Martin Dierich
Hannover Medical School
22 Papers
61 Citations
Martin Dierich is an academic researcher from Hannover Medical School. The author has contributed to research in topics: Lung transplantation & Transplantation. The author has an hindex of 12, co-authored 22 publications. Previous affiliations of Martin Dierich include Hochschule Hannover.
Chat about Author
Papers
Impact of graft colonization with gram-negative bacteria after lung transplantation on the development of bronchiolitis obliterans syndrome in recipients with cystic fibrosis
Jens Gottlieb,Frauke Mattner,H. Weissbrodt,Martin Dierich,Thomas Fuehner,Martin Strueber,Andre R. Simon,Tobias Welte +7 more
TL;DR: A significant proportion of post-LTx CF patients demonstrates subsequent GNB eradication during later follow-up and this may have a protective role against development of BOS, which is a leading cause of late mortality after lung transplantation (LTx).
110
Phenotyping established chronic lung allograft dysfunction predicts extracorporeal photopheresis response in lung transplant patients.
Mark Greer,Martin Dierich,C. de Wall,Hendrik Suhling,Jessica Rademacher,Tobias Welte,Axel Haverich,Gregor Warnecke,Philipp Ivanyi,Stefanie Buchholz,Jens Gottlieb,Thomas Fuehner +11 more
TL;DR: Proposed CLAD phenotypes require refinement, but appear to predict the likelihood of ECP response, and ECP appears an effective second line treatment in CLAD patients progressing under azithromycin.
96
Are metallic stents really safe? A long-term analysis in lung transplant recipients
TL;DR: In SEMS patients, 5-yr survival was significantly lower than in the total cohort (60% versus 76%; p = 0.02).
92
Health-Related Quality of Life in Long-Term Survivors After Heart and Lung Transplantation: A Prospective Cohort Study
Christiane Kugler,Uwe Tegtbur,Jens Gottlieb,Christoph Bara,D. Malehsa,Martin Dierich,Andre Simon,Axel Haverich +7 more
TL;DR: Both HTx and LTx patients benefit from the transplant procedure with respect to HRQoL improvements for at least 5 years posttransplant; however, their trajectories during this time interval differ.
73
Biodegradable stents after lung transplantation.
Thomas Fuehner,Hendrik Suhling,Mark Greer,Olaf Wiesner,Martin Dierich,Gregor Warnecke,Axel Haverich,Tobias Welte,Jens Gottlieb +8 more
TL;DR: Biodegradable stents have been developed as a temporary alternative in managing benign lesions and represent a novel alternative for obstructive AC in LTx recipients and are shown to be well tolerated by the tracheal mucosa, maintain biomechanical strength for 6 weeks, and dissolve completely after 3–4 months.
31